( en | de | ru )

 

Disambiguation of "Trümper, Lorenz"

Author of the publication

copydeleteadd this publication to your clipboard
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

, , , , , , , , , , , , and . Blood, 104 (3): 634–641 (2004)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Lorenz Trümper

Lorenz Trümper

Werner Trümper

Klaus Trümper

Georg Trümper

 

Other publications of authors with the same name

Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma, , , , , , , , , and . Blood, 107 (8): 3058–3064 (2006)Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), , , , , , , , , and 16 other author(s). The Lancet Oncology, 9 (2): 105–116 (2008)NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity, , , , , , , , , and 11 other author(s). Circulation, 112 (24): 3754–3762 (2005)Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis, , , , , , , , , and 8 other author(s). Haematologica, 95 (12): 2047–2055 (2010)Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group, , , , , , , , , and . Blood, 116 (18): 3418–3425 (2010)Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL, , , , , , , , , and 3 other author(s). Blood, 104 (3): 634–641 (2004)Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials, , , , , , , , , and 10 other author(s). Blood, 112 (4): 1374–1381 (2008)Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas, , , , , , , , , and 1 other author(s). International journal of cancer. Journal international du cancer, 131 (5): E830-5 (2012)Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma, , , , , , , , , and 1 other author(s). Clinical cancer research : an official journal of the American Association for Cancer Research, 18 (13): 3637–3647 (2012)Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma, , , , , , , , , and 9 other author(s). Haematologica, 93 (5): 688–696 (2008)